e-learning
resources
Vienna 2003
Tuesday 30.09.2003
Severe pulmonary infection and sepsis
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Acinetobacter baumani
and
Pseudomonas aeruginosa
drug susceptibility after bacteriological analysis of sputum in patients mechanically ventilated in ICU
G. Meletis, E. Astrinaki, M. Ferdoutsis, E. Vakouti, K. Hahlioutis, K. Antoniou, N. Zografistos, G. Vrouhos, N. Bachlitzanakis (Heraklion, Greece)
Source:
Annual Congress 2003 - Severe pulmonary infection and sepsis
Session:
Severe pulmonary infection and sepsis
Session type:
Thematic Poster Session
Number:
2859
Disease area:
Respiratory critical care, Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
G. Meletis, E. Astrinaki, M. Ferdoutsis, E. Vakouti, K. Hahlioutis, K. Antoniou, N. Zografistos, G. Vrouhos, N. Bachlitzanakis (Heraklion, Greece).
Acinetobacter baumani
and
Pseudomonas aeruginosa
drug susceptibility after bacteriological analysis of sputum in patients mechanically ventilated in ICU. Eur Respir J 2003; 22: Suppl. 45, 2859
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
A 62-year-old man with scanty mucoid sputum
Related content which might interest you:
Carbapenems for the treatment of immunocompetent adult patients with nosocomial pneumonia
Source: Eur Respir J 2007; 29: 548-560
Year: 2007
Antibiotic sensitivity of pseudomonas aeroginosa isolates of respiratory secretions taken from ICU patients of the NRITLD
Source: Eur Respir J 2004; 24: Suppl. 48, 641s
Year: 2004
Acinetobacter baumanii
as a severity marker in a respiratory ICU
Source: Eur Respir J 2006; 28: Suppl. 50, 786s
Year: 2006
Comparative results of preemptive therapies in mechanically ventilated patients with carbapanem-resistant Acinetobacter baumannii (CRAB)
Source: International Congress 2017 – Hospital-acquired infections: from prevention to treatment
Year: 2017
Clinical and microbiological characteristics of
Pseudomonas aeruginosa
isolates from patients with COPD
Source: Eur Respir J 2005; 26: Suppl. 49, 58s
Year: 2005
Acinetobacter baumanii and Stenotrophomonas maltophilia are associated with lower airway infections in tracheostomised children and young adults.
Source: International Congress 2017 – New insights into paediatric respiratory infections
Year: 2017
The resistance rates of Acinetobacter baumannii at endotracheal aspirate cultures
Source: Annual Congress 2012 - Respiratory infections: a clinical point of view
Year: 2012
Association of
acinetobacter baumannii
respiratory isolates with hospital outcomes in ventilated patients
Source: Eur Respir J 2006; 28: Suppl. 50, 785s
Year: 2006
Clinical outcomes of tigecycline in the treatment of critically ill patients with multidrug-resistant Acinetobactor baumannii infection
Source: Annual Congress 2011 - Antimicrobial treatment and resistance in lower respiratory tract infections
Year: 2011
Potential treatment for nosocomial respiratory strains of extreme drug resistant
acinetobacter baumanii
Source: Eur Respir J 2007; 30: Suppl. 51, 410s
Year: 2007
The clinical evaluation of patients with Pseudomonas aeruginosa detected in respiratory specimens
Source: Annual Congress 2012 - Management of pneumonia due to hospital pathogens
Year: 2012
Acinetobacter baumannii infection and colonization among pediatric patients in pediatric ICU and other ICUs
Source: International Congress 2018 – Neonatology and paediatric intensive care
Year: 2018
Community-acquired pneumonia through Enterobacteriaceae and Pseudomonas aeruginosa: diagnosis, incidence and predictors
Source: Eur Respir J 2010; 35: 598-615
Year: 2010
Aetiopathogenesis of VAP revisited
Source: Eur Respir Mon 2011; 53: 1-10
Year: 2011
Clinical profile and outcome of patients with sputum positive Acinetobacter baumanni infection
Source: International Congress 2018 – Difficult-to-treat respiratory infections
Year: 2018
Prognosis of
Acinetobacter baumannii
bacteraemia in a respiratory ICU: 10 years‘ experience
Source: Eur Respir J 2005; 26: Suppl. 49, 222s
Year: 2005
Novel Pseudomonas aeruginosa scoring system to guide empiric anti-pseudomonal therapy in COPD patients with community-acquired pneumònia
Source: Virtual Congress 2020 – Cardiovascular and pulmonary complications of respiratory infections
Year: 2020
Resistant and panresistant
A. baumanni
infection in ICU
Source: Annual Congress 2010 - Intensive care unit outcome
Year: 2010
Study on the molecular epidemiology of
stenotrophomonas maltophilia
infection in patients on mechanical ventilation
Source: Eur Respir J 2006; 28: Suppl. 50, 785s
Year: 2006
Pseudomonas aeruginosa
and
legionella pneumophilia
in water of dental units
Source: Eur Respir J 2006; 28: Suppl. 50, 486s
Year: 2006
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept